The group began with a discussion of the landmark agreement with Pfizer, which Lanton noted is a significant development ...

Craig See, MD, a cornea specialist for the Cole Eye Institute at Cleveland Clinic, emphasized taking proper safety precautions before dressing up for Halloween, including making sure to change eye ...

Artificial intelligence (AI) should assist clinicians in clinical decision-making, not replace them, says Vivek Subbiah, MD, chief of early-phase drug development at Sarah Cannon Research Institute, ...

Tiffany Mayo, MD, speaks on emerging therapies for treating hidradenitis suppurativa at the 2025 Skin of Color Update.

Improved patient care: Evidence-based RVIs can ensure timely follow-ups, enhancing continuity of care and patient outcomes. Cost efficiency: Minimizing unnecessary visits lowers health care costs and ...

UC Davis Health enhances patient care through a shared services center, ensuring continuity of care and optimizing pharmacy growth strategies.

An expert discusses how rilzabrutinib’s covalent reversible binding mechanism provides a favorable safety profile with only manageable grade 1 to 2 toxicities and no cardiovascular or bleeding ...

Surgeons who previously shared patients with physicians who frequently performed opportunistic salpingectomy (OS) were more likely to adopt the procedure themselves, according to a study published in ...

Lindsey Valenzuela, PharmD, explains how atypical symptoms, research gaps, and care inequities delay arrhythmia detection in women. Women with arrhythmia are too often overlooked—not because their ...

Although there are some positive aspects of the executive order “Ending Crime and Disorder on America’s Streets,” which ...

Bouchard opened a discussion on sequencing therapies in MM, noting that CAR T-cell therapy and bispecific antibodies each ...

An expert discusses how the phase 3 LUNA 3 trial demonstrated that rilzabrutinib achieved durable platelet responses in 23% of patients while also being the first prospective trial to show significant ...